Suppr超能文献

菲律宾草药产品的DNA条形码技术

DNA Barcoding of Philippine Herbal Medicinal Products.

作者信息

Pedales Ronniel D, Damatac Amor M, Limbo Carlo A, Marquez Cielo Mae D, Navarro Anna Isabel B, Molina Jeanmaire

机构信息

Institute of Biology, University of the Philippines Diliman, DNA Barcoding Laboratory, Quezon City, Philippines.

Institute of Biology, University of the Philippines Diliman, Mammalian Cell Culture Laboratory, Quezon City, Philippines.

出版信息

J AOAC Int. 2016 Nov 1;99(6):1479-1489. doi: 10.5740/jaoacint.16-0185. Epub 2016 Sep 21.

Abstract

The Philippine government established the Traditional and Alternative Medicine Act in 1997 to promote traditionally used herbal products and to provide an effective yet affordable alternative to conventional medicines. However, government regulation of herbal medicinal products (HMPs) is not stringent, relying only on submitted quality data from the manufacturer. In this study we validated the taxonomic identity of 26 plant samples contained within 22 HMPs, each produced by different local manufacturers, through DNA barcoding of the nuclear internal transcribed spacer-2 (ITS2) region. We recovered 19 ITS2 barcodes from 26 samples. These were compared to sequences in GenBank using MEGABLAST, but ambiguous results (similar max scores for different species) were phylogenetically analyzed. Twelve of the 19 samples matched the indicated species on the product label, three were equivocal in specific identity but were placed in the expected genus, and four other samples from three manufacturers contained contamination and/or substitution. GenBank's reference database was at times problematic because some sequences were lacking or were misidentified, but the database was still useful. Overall, ITS2 barcoding was successful in authenticating the HMPs, and it is recommended during the premarket evaluation process so as to obtain a certificate of registration from the government. The government should also develop a comprehensive database of barcodes for Philippine plants, and should prioritize the development of the traditional pharmacopeia because many locally produced HMPs are not indigenous.

摘要

菲律宾政府于1997年制定了《传统与替代医学法案》,以推广传统使用的草药产品,并提供一种有效且价格合理的传统药物替代品。然而,政府对草药产品(HMPs)的监管并不严格,仅依赖制造商提交的质量数据。在本研究中,我们通过对核内转录间隔区2(ITS2)区域进行DNA条形码分析,验证了22种由不同本地制造商生产的HMPs中所含26个植物样本的分类身份。我们从26个样本中获得了19个ITS2条形码。使用MEGABLAST将这些条形码与GenBank中的序列进行比较,但对结果不明确(不同物种的最大得分相似)的样本进行了系统发育分析。19个样本中有12个与产品标签上标明的物种匹配,3个在具体身份上模棱两可,但被归入预期的属,另外来自三个制造商的4个样本含有污染和/或替代物。GenBank的参考数据库有时存在问题,因为一些序列缺失或被错误识别,但该数据库仍然有用。总体而言,ITS2条形码分析成功地对HMPs进行了鉴定,建议在上市前评估过程中使用,以便从政府获得注册证书。政府还应建立一个菲律宾植物条形码的综合数据库,并应优先发展传统药典,因为许多本地生产的HMPs并非本土植物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验